bd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

Details for Australian Patent Application No. 2006200854 (hide)

Owner Les Laboratoires Servier

Inventors Horvath, Stephane; Auguste, MarieNoelle; Damien, Gerard

Agent Allens Arthur Robinson

Pub. Number AU-B-2006200854

Priority 05.01987 28.02.05 FR

Filing date 28 February 2006

Wipo publication date 14 September 2006

Acceptance publication date 17 February 2011

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

16 March 2006 Complete Application Filed

  Priority application(s): 05.01987 28.02.05 FR

14 September 2006 Application Open to Public Inspection

  Published as AU-B-2006200854

17 February 2011 Application Accepted

  Published as AU-B-2006200854

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200855-yd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

2006200853-Combinational therapy involving a small molecule inhibitor of the MDM2: P53 interaction